|
|||||
![]() |
|
Manufacturing services provider Proto Labs (NYSE:PRLB) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.3% year on year to $126.2 million. The company expects next quarter’s revenue to be around $128 million, close to analysts’ estimates. Its non-GAAP profit of $0.33 per share was 13.3% above analysts’ consensus estimates.
Is now the time to buy PRLB? Find out in our full research report (it’s free).
Proto Labs began 2025 with results that management attributed to growth in its production manufacturing offerings and targeted marketing investments. CEO Rob Bodor credited an increase in customers using the company’s combined prototyping and production services, noting, “Customers utilizing our combined offer grew more than 45% over the trailing 12 months and revenue per customer in Q1 increased by 3% year-over-year.” While macroeconomic headwinds continued to weigh on overall demand, the company emphasized sequential revenue improvements and a strong free cash flow contribution.
Looking ahead, Proto Labs’ leadership pointed to ongoing enhancements in its go-to-market strategy and fulfillment optimization as drivers for future growth. Management highlighted planned investments in advanced manufacturing capabilities and sustained marketing efforts to further position the company as a production manufacturer. CFO Dan Schumacher remarked that the company’s guidance for the next quarter accounts for expected margin pressures from a greater mix of network-fulfilled revenue, but added that operational efficiencies and flexible supply chains would remain key priorities.
Management focused on how recent strategic shifts and customer trends shaped first quarter performance and set the tone for 2025. The following were the most impactful drivers and business updates:
Management’s outlook for the next quarter and the year is shaped by a focus on production segment growth, continued marketing investment, and adaptability in response to global supply chain and tariff dynamics.
In the coming quarters, the StockStory team will monitor (1) the pace of growth in production manufacturing revenue as a signal of successful strategy execution, (2) the balance between factory- and network-fulfilled orders and its impact on gross margins, and (3) customer adoption rates for expanded manufacturing capabilities, particularly in target industries such as aerospace and defense. The effectiveness of ongoing marketing investments and operational streamlining will also be key areas of focus.
Proto Labs currently trades at a forward P/E ratio of 27.6×. Should you load up, cash out, or stay put? The answer lies in our free research report.
The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
May-16 | |
May-05 | |
May-03 | |
May-02 | |
May-02 | |
May-02 | |
May-02 | |
Apr-29 | |
Apr-17 | |
Apr-12 | |
Apr-11 | |
Apr-08 | |
Apr-08 | |
Mar-23 | |
Mar-18 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite